The low-cost, high-margin model — and twenty straight years of growth (1994)
Running an unglamorous formula, for a very long time
The heart of this decision lies in a second-generation leader from outside the founding family running one unglamorous formula for a very long time. What Saizu brought was neither a new product nor a new market, but a thoroughness of plain operation: confine locations to residential and suburban sites, pare costs to the bone, and raise the strength of the sales floor by developing people. That he could flatly say retailing creates nothing new, and that turning a profit is therefore only to be expected, was surely because he believed profit is born not of luck or a booming economy but of the daily design of operations. The length — twenty straight years — shows that this conviction was no passing thing.
That said, marrying low cost to high profit has a hidden face. The refusal to yield on price in contested areas, and the hard terms imposed on wholesalers, were the reverse side of that efficiency. The larger the scale grows, the heavier the question of how far this formula can be preserved. In later years, in fact, Sundrug kept its distance from the industry’s large mergers, choosing its own path through the two-format shift with Direx and loose capital alliances. Amid a competition that chases scale, how to inherit the low-cost, high-margin formula Saizu honed — that question remains with the company now that the manager from outside the founding family has gone.
Revenue and net margin, FY1989–FY1999
Revenue in ¥ bn (bars) and net margin in % (line), for the years around the decision. Shaded columns are FY1994 onwards — after it was taken.
Source: securities reports
Read the full dossier in Japanese →
The Japanese edition carries the complete record of this decision — the situation that forced it, the options weighed, what actually followed, and the sources behind every claim.
Other key decisions at Sundrug
Yen amounts are converted at the average rate of each figure’s own year — not today’s rate; the revenue chart is shown in yen. Exchange rates & sources — the full ¥/US$ table →
Disclaimer
- This page is provided for general information only and is not investment advice, nor a recommendation to buy or sell any security.
- Figures are compiled independently and include our own estimates, approximations and machine-processed data; we make no warranty as to their accuracy or completeness.
- Sources are primarily each company’s securities reports and other public filings, but errors and omissions may remain.
- Any use of this information is at the reader’s own risk. Past performance does not indicate future results.
- Company names, logos and other marks belong to their respective owners.
Data API
Sundrug’s history, financials, executives and
shareholders are published as static JSON — no key, plain GET.
Full specification →
| Method | Endpoint | Returns |
|---|---|---|
| GET | /api/companies.json | All companies |
| GET | /api/9989/manifest.json | Resource index |
| GET | /api/9989/history.json | History overview |
| GET | /api/9989/timeline.json | Chronology |
| GET | /api/decisions.json | All management decisions (index) |
| GET | /api/9989/decisions.json | Management decisions (index) |
| GET | /api/9989/decisions/{slug}.json | One decision (full dossier) |
| GET | /api/9989/executives.json | Executives |
| GET | /api/9989/shareholders.json | Major shareholders |
| GET | /api/9989/financials.json | Financial statements |
| GET | /api/9989/financials-longterm.json | Long-term results |
| GET | /api/9989/segments.json | Business segments |
| GET | /api/9989/regions.json | Sales by region |
| GET | /api/9989/workforce.json | Workforce |